Flu Vaccine Administration After Taking Jubbonti
The flu vaccine can be safely administered after taking Jubbonti (tezepelumab), as there are no specific contraindications or interactions between these medications. Injectable inactivated influenza vaccines (IIV) can be administered to persons receiving other medications without concern for interactions 1.
Types of Influenza Vaccines and Considerations
There are two main types of influenza vaccines to consider:
- Inactivated Influenza Vaccines (IIV) can be administered to persons receiving other medications without any special timing considerations 1
- Live Attenuated Influenza Vaccine (LAIV) requires special consideration with certain medications, but not with biologics like Jubbonti 1
Administration Guidelines
When administering the flu vaccine after Jubbonti:
- No waiting period is required between Jubbonti administration and receiving an inactivated influenza vaccine 2
- Separate injection sites should be used if both medications are administered on the same day 2
- No dose adjustments are needed for either medication 3
Special Considerations
Medication Interactions
- Unlike influenza antiviral medications (such as oseltamivir, zanamivir, peramivir, or baloxavir) which may interfere with live attenuated influenza vaccines, Jubbonti (tezepelumab) has no known interference with any influenza vaccine formulations 1
- Jubbonti is a biologic agent that targets thymic stromal lymphopoietin (TSLP) and does not have the same immunosuppressive properties as some other biologics that might affect vaccine response 3
Immunosuppressive Considerations
- For patients on immunosuppressive medications, the CDC recommends inactivated vaccines rather than live vaccines 1
- While Jubbonti is a biologic agent, it is not considered immunosuppressive in the same way as medications like rituximab, which would require special timing considerations for vaccination 1
Practical Recommendations
For most patients taking Jubbonti:
If considering Live Attenuated Influenza Vaccine (LAIV):
For optimal vaccine effectiveness:
Common Pitfalls to Avoid
- Don't delay influenza vaccination unnecessarily - timely vaccination is important for protection against seasonal influenza 2
- Don't confuse Jubbonti with immunosuppressive biologics like rituximab that would require special vaccination timing 1, 5
- Don't administer live vaccines to patients who are severely immunocompromised, though Jubbonti itself is not considered to cause severe immunosuppression 1
In summary, patients taking Jubbonti can safely receive their annual influenza vaccination without any special timing considerations or dose adjustments. The inactivated influenza vaccine is appropriate for all patients, while the live attenuated vaccine may be an option for eligible patients who are not otherwise immunocompromised.